Both in Pharmaceuticals
TuHURA Biosciences vs Upstream Bio
Over the past year HURA returned −2.2% and UPB returned −87.0%; their daily moves had a correlation of 0.11.
HURA −2.2% UPB −87.0%Growth of $1, one year, split-adjusted
| Metric | HURA | UPB |
|---|---|---|
| Price | $2.18 | $2.74 |
| Market cap | $138.9M | $150.1M |
| Today | +8.46% | −8.36% |
| 1 month | +3.8% | −47.0% |
| 6 months | −7.2% | −70.5% |
| Year to date | +188.1% | −89.9% |
| 1 year | −3.1% | −87.6% |
| Revenue growth (YoY) | — | −17.5% |
| Gross margin | — | 100.0% |
| Net margin | — | −5136.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 47.5× |
| Net cash | -$4.2M | $261.3M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 79.8% |
| Short % of float | 13.7% | 13.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).